CTLA 4 News and Research

RSS
Immunotherapy Response in Advanced Melanoma: Effect of Previous Treatments

Immunotherapy Response in Advanced Melanoma: Effect of Previous Treatments

Neoadjuvant dual immunotherapy and chemotherapy improve outcomes in patients with resectable NSCLC

Neoadjuvant dual immunotherapy and chemotherapy improve outcomes in patients with resectable NSCLC

Pioneering gene editing approach could lead to new treatments for CTLA-4 insufficiency

Pioneering gene editing approach could lead to new treatments for CTLA-4 insufficiency

New strategy to improve the therapeutic efficacy of liver cancer immunotherapy

New strategy to improve the therapeutic efficacy of liver cancer immunotherapy

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

New molecule can effectively deplete cancer-protecting cells inside tumors

New molecule can effectively deplete cancer-protecting cells inside tumors

Study identifies how CTLA-4 blockade can disable suppressive immune cells to aid tumor destruction

Study identifies how CTLA-4 blockade can disable suppressive immune cells to aid tumor destruction

Study suggests a way to improve immunotherapy by altering immune cells’ access to sugar

Study suggests a way to improve immunotherapy by altering immune cells’ access to sugar

Researchers identify a vital protein needed to regulate anti-tumor immune response

Researchers identify a vital protein needed to regulate anti-tumor immune response

Study unravels how immunotherapy is 'uniquely suppressed' by liver cancers

Study unravels how immunotherapy is 'uniquely suppressed' by liver cancers